From the Guidelines
The management of acute sickle cell crisis requires prompt intervention with pain control, hydration, and treatment of underlying triggers, with consideration of transfusion support as outlined in the American Society of Hematology 2020 guidelines 1. The primary goal is to reduce morbidity, mortality, and improve quality of life by addressing the vaso-occlusive pathophysiology of sickle cell crisis.
Key Components of Management
- Rapid pain assessment and administration of opioid analgesics such as morphine (0.1-0.15 mg/kg IV every 2-4 hours) or hydromorphone (0.015-0.02 mg/kg IV every 3-4 hours) 1
- Aggressive IV hydration with isotonic fluids at 1.5 times maintenance rate, being careful to avoid overhydration which can precipitate acute chest syndrome
- Administer supplemental oxygen if oxygen saturation is below 95%
- Identify and treat precipitating factors such as infection (with appropriate antibiotics), dehydration, or extreme temperatures
- Monitor vital signs, oxygen saturation, and pain scores frequently
Transfusion Support
For severe cases unresponsive to initial management, consider exchange transfusion to reduce the percentage of sickled cells, with the choice of simple transfusion, manual red cell exchange (RCE), or automated RCE depending on the clinical scenario and available resources 1.
Additional Therapies
- Incentive spirometry (10 breaths every 2 hours while awake) helps prevent pulmonary complications
- NSAIDs like ketorolac (0.5 mg/kg IV/IM, max 30mg) can be added as adjunctive therapy The American Society of Hematology 2020 guidelines recommend a comprehensive approach to managing acute sickle cell crisis, including transfusion support, to improve patient outcomes and reduce SCD-related complications 1.
From the Research
Management Protocol for Acute Sickle Cell Crisis
The management of acute sickle cell crisis involves several key components, including:
- Prompt medical intervention to provide relief and comfort to the patient 2
- Effective analgesia, with a focus on opioid analgesics for pain management 3, 4
- Intravenous hydration, with careful consideration of the choice of IV fluids and rate of administration to avoid adverse outcomes such as fluid overload and pulmonary edema 2, 5
- Vigorous antibiotic therapy for infections, which are a leading cause of morbidity and mortality in sickle cell disease 2
- Oxygen administration reserved for hypoxic patients, and blood transfusion given only when really indicated 2, 6
- Urgent attention for life-threatening complications such as acute chest syndrome, cerebrovascular accidents, and priapism 2, 6
Pain Management
Pain management is a critical component of acute sickle cell crisis management, with:
- Regular intravenous narcotic analgesia for the initial 24 hours, supplemented by oral analgesia, useful for adult patients with severe acute sickle cell pain crisis 4
- Alternatives to morphine, and intranasal or transmucosal routes of administration, potentially improving management of acute sickle pain 3
- Consideration of gender differences in pain perception and response in acute sickle cell pain crisis 4
Hydration and Transfusion
Intravenous hydration and transfusion are important aspects of acute sickle cell crisis management, with:
- A 5% dextrose solution or 5% dextrose in 25% normal saline recommended for intravenous hydration 2
- Blood transfusion given only when really indicated, such as in cases of aplastic crisis or severe anemia 2, 6
- Careful monitoring of patients receiving strong opioids and transfusions to ensure efficacy, safety, and patient satisfaction 3, 6